Skip to search formSkip to main contentSkip to account menu

masitinib

Known as: 4-((4-methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide, masatinib 
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (3)

AB 1010kinavet CA-1masivet
Inhibition of Cell ProliferationPositive Regulation of ApoptosisReceptor Tyrosine Kinase InhibitionSignal Transduction Inhibition

Broader (1)

Thiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
FDA approves first new ALS drug in over 20 years
2017
2017
Esclerosis Lateral Amiotrófica: Enfermedad, tratamiento actual y nuevas líneas de investigación. Masitinib
La Esclerosis Lateral Amiotrofica (ELA), es una enfermedad degenerativa de las neuronas motoras que afecta tanto a hombres como a… 
Review
2017
Review
2017
Immuno-oncology upset in bladder cancer
is unknown, it is a radical scavenger with antioxidant effects that might provide neuroprotection against oxidative stress in… 
Review
2016
Review
2016
Review of the Treatment of Canine Cutaneous Mast Cell Tumors
  • G.
  • 2016
  • Corpus ID: 47936569
ABST RACT The most common skin tumor in dogs is the mast cell tumor, with an incidence of close to 20% in the canine population… 
Review
2016
Review
2016
Review of the Treatment of Canine Cutaneous Mast Cell Tumors. In: Israel Journal of Veterinary Medicine - Vol. 71 - N°2 - Jun. 2016
  • G.
  • 2016
  • Corpus ID: 47760987
ABST RACT The most common skin tumor in dogs is the mast cell tumor, with an incidence of close to 20% in the canine population… 
2014
2014
Utilisation hors AMM des inhibiteurs des tyrosine-kinases en cancérologie vétérinaire
EnglishTyrosine-kinase inhibitors (TKI) are a recent class of anticancer drug, with two agents approved in veterinary medicine… 
2014
2014
Inhibition of Cell Signalling in Neoplastic Canine Mast Cells
Inhibition of cell signalling in neoplastic canine mast cells Sean Masson Advisor: University of Guelph, 2014 Dr. B. L. Coomber… 
2013
2013
Drugs in Clinical Development for Multiple Myeloma : Summary and Table
  • 2013
  • Corpus ID: 18335997
2013
2013
Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors
The present invention relates to a method for treating patients afflicted with cancer, wherein said patients are treated with a… 
2011
2011
Abstracts presented at the ESVONC Annual Congress, Turin, Italy, 18-20 March 2010.